{"entity":{"type":"insider","cik":"0001687436","url":"/insider/0001687436","json_url":"/insider/0001687436.json","name":"Mattsson Jan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":10,"first":"2018-06-14","last":"2023-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Mattsson Jan","source":"filing","n_filings":10,"first_seen":"2018-06-14","last_seen":"2023-01-23"}],"transactions":[{"id":8573065,"accession":"0001209191-23-004455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004455","line_url":"/filing/0001209191-23-004455#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":197.0,"shares_display":"197","price_per_share":43.8,"price_display":"43.80","price_state":"stated","total_value":8628.6,"total_display":"8,628.60","total_whole":"8,629","shares_owned_after":54474.0,"shares_owned_after_display":"54,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-23","scope":"insider"},{"id":8214256,"accession":"0001209191-23-004222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004222","line_url":"/filing/0001209191-23-004222#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3088.0,"shares_display":"3,088","price_per_share":43.8,"price_display":"43.80","price_state":"stated","total_value":135254.4,"total_display":"135,254.40","total_whole":"135,254","shares_owned_after":54671.0,"shares_owned_after_display":"54,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-20","scope":"insider"},{"id":6399335,"accession":"0001209191-22-054489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054489","line_url":"/filing/0001209191-22-054489#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":202.0,"shares_display":"202","price_per_share":19.5764,"price_display":"19.58","price_state":"stated","total_value":3954.4328,"total_display":"3,954.43","total_whole":"3,954","shares_owned_after":57759.0,"shares_owned_after_display":"57,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-25","scope":"insider"},{"id":6699510,"accession":"0001209191-22-043112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043112","line_url":"/filing/0001209191-22-043112#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":205.0,"shares_display":"205","price_per_share":24.6752,"price_display":"24.68","price_state":"stated","total_value":5058.416,"total_display":"5,058.42","total_whole":"5,058","shares_owned_after":57961.0,"shares_owned_after_display":"57,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-25","scope":"insider"},{"id":6147801,"accession":"0001209191-22-025526","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025526","line_url":"/filing/0001209191-22-025526#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":32.9247,"price_display":"32.92","price_state":"stated","total_value":6584.94,"total_display":"6,584.94","total_whole":"6,585","shares_owned_after":58166.0,"shares_owned_after_display":"58,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-22","filed_date":"2022-04-25","scope":"insider"},{"id":6749735,"accession":"0001209191-22-004803","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-004803","line_url":"/filing/0001209191-22-004803#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":808.0,"shares_display":"808","price_per_share":24.8822,"price_display":"24.88","price_state":"stated","total_value":20104.8176,"total_display":"20,104.82","total_whole":"20,105","shares_owned_after":58366.0,"shares_owned_after_display":"58,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-25","scope":"insider"},{"id":9271410,"accession":"0001209191-21-018051","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-018051","line_url":"/filing/0001209191-21-018051#line-5","is_derivative":false,"issuer_cik":"0001687436","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001687436","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":36.2025,"price_display":"36.20","price_state":"stated","total_value":14481.0,"total_display":"14,481.00","total_whole":"14,481","shares_owned_after":37574.0,"shares_owned_after_display":"37,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-05","scope":"insider"},{"id":4178007,"accession":"0001209191-21-017282","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-017282","line_url":"/filing/0001209191-21-017282#line-6","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":36.2025,"price_display":"36.20","price_state":"stated","total_value":14481.0,"total_display":"14,481.00","total_whole":"14,481","shares_owned_after":37574.0,"shares_owned_after_display":"37,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-03","scope":"insider"},{"id":9271412,"accession":"0001209191-21-018051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-018051","line_url":"/filing/0001209191-21-018051","is_derivative":false,"issuer_cik":"0001687436","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001687436","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15770.0,"shares_display":"15,770","price_per_share":36.28454904248573,"price_display":"36.28","price_state":"stated","total_value":572207.3384,"total_display":"572,207.34","total_whole":"572,207","shares_owned_after":41393.0,"shares_owned_after_display":"41,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-05","scope":"insider","n_lines":3},{"id":4178003,"accession":"0001209191-21-017282","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-017282","line_url":"/filing/0001209191-21-017282","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15770.0,"shares_display":"15,770","price_per_share":36.28454904248573,"price_display":"36.28","price_state":"stated","total_value":572207.3384,"total_display":"572,207.34","total_whole":"572,207","shares_owned_after":41393.0,"shares_owned_after_display":"41,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-03","scope":"insider","n_lines":3},{"id":9271413,"accession":"0001209191-21-018051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-018051","line_url":"/filing/0001209191-21-018051#line-1","is_derivative":false,"issuer_cik":"0001687436","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001687436","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15300.0,"shares_display":"15,300","price_per_share":37.4507,"price_display":"37.45","price_state":"stated","total_value":572995.71,"total_display":"572,995.71","total_whole":"572,996","shares_owned_after":53744.0,"shares_owned_after_display":"53,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-05","scope":"insider"},{"id":4177994,"accession":"0001209191-21-017282","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-017282","line_url":"/filing/0001209191-21-017282#line-2","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15300.0,"shares_display":"15,300","price_per_share":37.4507,"price_display":"37.45","price_state":"stated","total_value":572995.71,"total_display":"572,995.71","total_whole":"572,996","shares_owned_after":53744.0,"shares_owned_after_display":"53,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":2083514,"accession":"0001209191-20-050079","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-050079","line_url":"/filing/0001209191-20-050079#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":45.55,"price_display":"45.55","price_state":"stated","total_value":455500.0,"total_display":"455,500.00","total_whole":"455,500","shares_owned_after":24214.0,"shares_owned_after_display":"24,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":6046840,"accession":"0001209191-18-037907","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-037907","line_url":"/filing/0001209191-18-037907#line-3","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6903.0,"shares_display":"6,903","price_per_share":32.08,"price_display":"32.08","price_state":"stated","total_value":221448.24,"total_display":"221,448.24","total_whole":"221,448","shares_owned_after":34214.0,"shares_owned_after_display":"34,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-13","filed_date":"2018-06-14","scope":"insider"},{"id":6046838,"accession":"0001209191-18-037907","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-037907","line_url":"/filing/0001209191-18-037907","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001687436","owner_name":"Mattsson Jan","owner_display_name":"Mattsson Jan","owner_url":"/insider/0001687436","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18097.0,"shares_display":"18,097","price_per_share":32.32913024258164,"price_display":"32.33","price_state":"stated","total_value":585060.27,"total_display":"585,060.27","total_whole":"585,060","shares_owned_after":43538.0,"shares_owned_after_display":"43,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-12","filed_date":"2018-06-14","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001322505","name":"ALBIREO PHARMA, INC.","url":"/issuer/0001322505","role":"Officer (Chief Scientific Officer)","n_filings":10,"first_seen":"2018-06-14","last_seen":"2023-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001687436","retrieved_at":"2026-08-23T14:32:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}